Christopher J. Logothetis, MD of MD Anderson Cancer Center discusses how he identifies and chooses the right patients for abiraterone and enzalutamide at the 2017 Annual Meeting Annual Meeting in Chicago, IL.
Identifying the right patient for Zytiga (Abiraterone) or Xtandi (Enzalutamide)
